; ; ; ; Updated in 2565 : on 2022 : 1 : 10 : Specialties O B G, Obstetrics and Gynecology a.k.a. Ob/G y n;

Abnormal Uterine Bleeding; [Egg Follicle OR Fallopian Tubes OR Ovaries OR Uterus OR Vagina];

Birth control: Cervical cap Real-time, Contraceptive pills Daily, Copper-T IUD 10 years, Diaphragm Real-time, Female condom Real-time, Injectable 3 months, LNG-IUS 5 years, Male condom Real-time, Progestin-only pills Daily, Transdermal contraceptive patch Weekly, Vaginal ring Monthly, ... ; [Female Patient, OB/GYN Edition; Vol.30, No.8; 2005];

BMD, Bone Mineral Density [Contemporary OB/GYN vol.50; no.1; 2005]; Also see: Space BMD;

BMI, Body Mass Index, kg/m² *Index;  

BPP, Biophysical Profile [Obstetrical & Gynecological Survey; Vol. 60; No.1];

Breast Pain;

CRF, Corticotrophin releasing factor [Obstetrical & Gynecological Survey; Vol. 60; No.1];  

CS, Cesarean Section [Obstetrical And Gynecological Survey; Vol.60; No.4];

Disorder; Also see: Disease Disorder Acronym;

Endometriosis; Inside vitro, endometrial stromal cells proliferate by inhibition [Also see: inhibitor] of Nitric Oxide; [www.pusan.ac.kr; 2005; The Journal of Reproductive Medicine, Vol.50, No.9];

FHF, Fulminant Hepatic Failure [Obstetrical & Gynecological Survey; Vol. 60; No.1; Lippincott Williams & Wilkins];

FSD, Female Sexual Dysfunction;  

HPV DNA, Human Papillomavirus DNA [The Female Patient; Vol. 30; No. 4]; HPV screening with Pap, Cervical disease screening; Digene; ThinPrep;

HRT, Hormone Replacement Therapy;

ICSI, Intracytoplasmic Sperm Injection [The Journal of Reproductive Medicine; Vol. 50; No. 3];  

IGF, Insulin like Growth Factor [Obstetrical And Gynecological Survey; Vol.60; No.4];

IUD, Intrauterine Device;  

IVF, In Vitro Fertilization [The Journal of Reproductive Medicine; Vol. 50; No. 3];  

LH/FSH, Luteinizing Hormone / Follicle Stimulating Hormone [Obstetrical And Gynecological Survey; Vol.60; No.4];

m/z ratio; m/z ratio is a computational protein result to define whether prenatal NORMAL or prenatal DISEASE during pregnancy prenatal care period; Genetic biometrics pap smear by using protein chip;

MPA, Medroxyprogesterone Acetate [The Female Patient; Vol. 30; No.4];

MSH, Massive Subchorionic Hematoma [The Journal of Reproductive Medicine; Vol. 50; No. 3];

NAF, Nipple Aspiration Fluid;

NBW, Normal Birth Weight [Obstetrical And Gynecological Survey; Vol.60; No.4];

NETA, Norethindrone Acetate [The Female Patient; Vol. 30; No.4], Testosterone;

NG, Norgestimate, Testosterone [The Female Patient; Vol. 30; No.4];

OC, Oral Contraceptives;

to prevent fracture, regarding Pt with low BMD (osteoporosis), also see: 2561 2018 CME (Q&A) no. 130;

Osteoporosis, women skeletal disorder; Skeletal;

Pap, Papanicolaou;

PAPP-A, Pregnancy Associated Plasma Protein;

PCOS, Polycystic Ovary Syndrome [Obstetrical & Gynecological Survey; Vol. 60; No.1];

PEPI, Postmenopausal Estrogen - Progestin Intervention [Premarin; Wyeth Pharmaceuticals; OBG Management; Vol.17; No.1];

PID, Pelvic Inflammatory Disease [OBG Management; Vol.17; No.1];

PMDD, Premenstrual Dysphoric Disorder [Contemporary OB/GYN vol.50; no.1; 2005];

PME, Premenstrual Exacerbation;

PMS, Premenstrual Syndrome;

Postmenopausal osteoporosis Estradiol [The Female Patient OB/GYN Edition; Vol.30; No.1];

PTSD, Post-traumatic Stress Disorder [OBG Management; Vol.17; No.1];

SERM, Selective Estrogen Receptor Modulator;

SHBG, Sex Hormone Binding Globulin;

Skin disorder; D;

SUI, Stress Urinary Incontinence;

( TSH, TSH, TSH, TSH) e.g. TSH (pregnant patient (Pt)): Reference Range is (0.1 - 3.0 ulU/mL), also see: index; tGTSU;

TVT, Tension-free Vaginal Tape Allocation [Obstetrical & Gynecological Survey; Vol.60; No.1];  

UAE, Uterine Artery Embolization [Obstetrical And Gynecological Survey; Vol.60; No.4];

UFE, Uterine Fibroid Embolization [Obstetrical And Gynecological Survey; Vol.60; No.4];

Vaginal Hemorrhage, Urogenital System; Vaginal Moniliasis, Urogenital System; Vaginitis, Urogenital System;  Uro;

Visual abnormalities [Menopausal/Cenestin; The Female Patient; Vol.30; No.1];

VBAC, Vaginal Birth After Cesarean Delivery [Obstetrical & Gynecological Survey; Vol.60; No.1];  

VTE, Venous Thromboembolic; Event [OBG Management; Vol.17; No.1];

VVC, Vulvovaginal Candidiasis;

Gene Therapy System;

	Up